BioNTech shares are trading higher following a recent Israeli study showing effectiveness of Pfizer-BioNTech booster shots against the omicron variant of COVID-19.

by | Dec 13, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.